MSEE

MediaTek's Chairman Ming-Kai Tsai Awarded Prestigious IEEE Robert N. Noyce Medal

Retrieved on: 
Wednesday, November 29, 2023
National Chiao Tung University, IEEE, MediaTek, United Microelectronics Corporation, Research, STEM, National Tsing Hua University, University, ITRI, Industrial Technology Research Institute, CEDA, Electronics, Electrical engineering, College, Semiconductor, Nobel Prize, Former, Culture, Computer science, MSEE, TSMC, BSEE, IC, Electronic, UMC, National Taiwan University, Pleasure, Video game, Boston

HSINCHU, Nov. 28, 2023 /PRNewswire/ -- MediaTek today announced its chairman Ming-Kai Tsai has been awarded the IEEE Robert N. Noyce Medal, one of the most prestigious awards in the electronics industry. Chairman Tsai was recognized for his vision and leadership in the global semiconductor industry, democratizing technology access for billions of people. The award will be presented to Tsai in-person at the IEEE Honors Ceremony, which will be held May 3, 2024 in Boston.

Key Points: 
  • HSINCHU, Nov. 28, 2023 /PRNewswire/ -- MediaTek today announced its chairman Ming-Kai Tsai has been awarded the IEEE Robert N. Noyce Medal, one of the most prestigious awards in the electronics industry.
  • Chairman Tsai was recognized for his vision and leadership in the global semiconductor industry, democratizing technology access for billions of people.
  • The award will be presented to Tsai in-person at the IEEE Honors Ceremony, which will be held May 3, 2024 in Boston.
  • " IEEE Robert N. Noyce Medal is an extremely important award, holding a special place in the global semiconductor industry.

FDA Grants Breakthrough Device Status to Toku’s Patented Cardiovascular Risk AI (CLAiR) Platform

Retrieved on: 
Thursday, November 2, 2023
Software, Professional Services, Pharmaceutical, Optical, Venture Capital, Technology, Medical Devices, Artificial Intelligence, Cardiology, Biotechnology, Medical Supplies, FDA, Health, Stanford University, Food, Genetics, Mortality, Breakthrough, Disease, Entrepreneurship, Regulation of tobacco by the U.S. Food and Drug Administration, Multimedia, CVD, American Heart, Risk, Hypertension, Health equity, Risk assessment, Pharmacy, Eye, Blood, AI, European Journal of Preventive Cardiology, MSEE, Patient, Emory University School of Medicine, Retina, Clair, Cardiovascular disease, Medical device, Medical imaging, Pharmaceutical industry, Ophthalmology, MD

Toku, Inc., a commercial medical device company specializing in imaging technology and AI, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to its patented CLAiR technology.

Key Points: 
  • Toku, Inc., a commercial medical device company specializing in imaging technology and AI, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to its patented CLAiR technology.
  • The CLAiR platform, if cleared by the FDA, will be the first medical device in the US market that can provide affordable, point-of-care and non-invasive evaluation for risk of cardiovascular disease (CVD) using fundus retinal images through a routine eye exam.
  • Working with its partners, Toku is aiming to establish the largest network for CVD risk assessment across the US and then globally.
  • View the full release here: https://www.businesswire.com/news/home/20231102799522/en/
    Toku's AI-powered CLAiR technology uses retina scans during regular eye exams to detect cardiovascular risk non-invasively.

Airgain Adds a Global Wireless Connectivity Veteran As Vice President of Engineering

Retrieved on: 
Monday, October 16, 2023
Technology, Mobile, Wireless, Engineering, 5G, Manufacturing, Networks, Internet, Hardware, IOT (Internet of Things), Systems engineering, Multimedia, Knowledge, Illinois Institute of Technology, Digital signal, Computer, Original equipment manufacturer, Michigan State University, BSEE, CDMA, Sierra Wireless, Computer engineering, Architecture, Motorola, NXP Semiconductors, Internet of things, Digital signal processing, MSEE, VLSI Technology, Mobile phone

Airgain, Inc. (NASDAQ: AIRG) , a leading provider of wireless connectivity solutions that creates and delivers embedded components, external antennas, and integrated systems across the globe, announced that Evan Jones, former Vice President of System Engineering for Sierra Wireless, joined its executive team as Vice President of Engineering.

Key Points: 
  • Airgain, Inc. (NASDAQ: AIRG) , a leading provider of wireless connectivity solutions that creates and delivers embedded components, external antennas, and integrated systems across the globe, announced that Evan Jones, former Vice President of System Engineering for Sierra Wireless, joined its executive team as Vice President of Engineering.
  • With over 30 years of experience in engineering management and wireless product development, Jones is a well-known and proven veteran in the IoT industry.
  • View the full release here: https://www.businesswire.com/news/home/20231016069917/en/
    Evan Jones Vice President of Engineering at Airgain (Photo: Business Wire)
    “Evan Jones brings a deep well of experience and knowledge alongside a proven track record of leading engineering and customer-technical teams,” said Airgain CEO Jacob Suen.
  • Airgain is a global leader in wireless innovation and technology, and that is exactly where I want to be at this next phase of my career.

VoxelSensors Strengthens the Board with Tim Droz and Youssef Benmokhtar. Company to Exhibit at AWE in Singapore on August 30-31, 2023

Retrieved on: 
Tuesday, August 22, 2023
Industrial engineering, MSEE, Semiconductor, Sony Depthsensing Solutions, Electronics, Electrical engineering, Perception, 3D, Business, Microsoft, Georgia Institute of Technology Institute for Robotics and Intelligent Machines, Magic Leap, Advisory board, 2D, Computer, Bangladesh Technical Education Board, Rochester Institute of Technology, DigitalOptics Corporation, Growth, Seed, Andromeda, XR, SVP, AR, 3D printing, Video game, Canesta

At AWE Asia in Singapore on August 30-31, VoxelSensors will showcase its Andromeda (gen 1) Evaluation Kit at booth #D3 (contact [email protected] for information and purchases).

Key Points: 
  • At AWE Asia in Singapore on August 30-31, VoxelSensors will showcase its Andromeda (gen 1) Evaluation Kit at booth #D3 (contact [email protected] for information and purchases).
  • Tim Droz (USA) joins the company as an independent board of directors member, while Youssef Benmokhtar (USA) joins the advisory board.
  • Tim Droz has recently become an independent Board member at VoxelSensors, enriching the board of directors with his vast leadership experience in consumer electronics, perception engineering, and executive management.
  • “I am excited to join the Board of VoxelSensors and contribute to the company's remarkable journey of innovation and growth,” said Tim Droz.

Motif Neurotech Strengthens Leadership Team with Appointment of Steven Goetz as Chief Technology Officer

Retrieved on: 
Monday, July 24, 2023
Biotechnology, Health, Mental Health, Medical Devices, MSEE, Spinal cord stimulator, Depression, University, Rice University, Research, Multimedia, Brain, Rose–Hulman Institute of Technology, Medtronic, Publication, Computer engineering, BSEE, Engineering, Growth, R, TRD, Mental health, Electricity, Medical device, Motif, Neuromodulation

Motif Neurotech , a clinical-stage company developing minimally invasive bioelectronics for mental health, announces the appointment of Steven Goetz as Chief Technology Officer.

Key Points: 
  • Motif Neurotech , a clinical-stage company developing minimally invasive bioelectronics for mental health, announces the appointment of Steven Goetz as Chief Technology Officer.
  • “I’m so excited to add him to our team – Steve is my dream candidate for this role.
  • “Motif has developed an elegant new way to deliver neuromodulation therapy to the brain that avoids many of the barriers of more invasive approaches, and I’m excited to join the company at this time of growth to help translate this innovative technology to market,” said Steven Goetz, new Chief Technology Officer of Motif Neurotech.
  • He holds a BSEE from Rose-Hulman Institute of Technology and an MSEE from the University of Minnesota.

Phoenix Motorcars Promotes Dr. Frank Lee and Adds Dr. Joseph Xiang to Senior Management Team

Retrieved on: 
Monday, April 24, 2023
Automotive Manufacturing, EV, Electric Vehicles, Automotive, Manufacturing, Trucking, Transport, General Automotive, Alternative Vehicles, Fuels, Logistics, Supply Chain Management, Alternative Energy, Energy, Karma, MSEE, Ohio State University, BS, University, Smart electric drive, MI, Visteon, Engineering, ICE, PEV, PHEV, Ford, Huachung University, EREV, BYD Auto, BSEE, Karma Automotive, Huazhong University of Science and Technology, Geely, Corporation, CFO, Knowledge, Phoenix Motorcars, Management, Electricity, Mechanics

“We are proud to be able to attract such talented, seasoned industry veterans,” said Dr. Lance Zhou, CEO of Phoenix Motorcars.

Key Points: 
  • “We are proud to be able to attract such talented, seasoned industry veterans,” said Dr. Lance Zhou, CEO of Phoenix Motorcars.
  • “The promotion of Frank and the addition of Joseph to our senior management team further positions Phoenix for success as we continue to execute on our global growth strategy.”
    Chris Wang, CFO of Phoenix Motorcars, commented, “The promotion of Frank and addition of Joseph lends additional knowledge and expertise to our operational and technical capabilities.
  • I am proud of the team we have built and our successes to date.
  • Dr. Joseph Xiang brings 35 years of engineering experience, with more than 25 years in the automotive arena.

FDA authorizes marketing of Medasense's NOL® (nociception level index) technology through a De Novo grant

Retrieved on: 
Thursday, February 23, 2023
Pain management, Blood pressure, Anesthesia, De novo sequence assemblers, De novo, MSEE, Heart rate, Algorithm, FDA, NOL, Patient, Regulation of tobacco by the U.S. Food and Drug Administration, Nociception, Operating, Vital signs, Analgesic, Movement, Hospital, Food, Pharmaceutical industry, Medical imaging, Nursing, MD, Pain

RAMAT GAN, Israel, Feb. 23, 2023 /PRNewswire/ -- Medasense Biometrics Ltd. announced today that  the U.S. Food and Drug Administration (FDA) has granted marketing authorization to the PMD-200 patient monitor with NOL® technology developed for  monitoring nociception (the physiological response to pain) through the De Novo premarket review pathway.

Key Points: 
  • NOL uses a unique multi-parametric sensor platform and advanced AI algorithms to convert complicated data into a patient's 'Signature of Pain.'
  • The technology, which is currently utilized in operating rooms and high-acuity settings, where patients are under anesthesia and unable to communicate, enables clinicians to personalize pain management, control pain and avoid overmedication.
  • "Our mission is to help patients suffer less from pain and the adverse effects of pain medication.
  • Relying on patient's heart rate and blood pressure is neither specific nor sensitive enough to pain.

Syntiant Corp. Strengthens Board of Directors with Appointment of Edward Frank

Retrieved on: 
Tuesday, October 25, 2022
Deep learning, Intel Capital, Growth, Communication, GLOBE, MSEE, Trustee, Solution, SITM, BSEE, Wi-Fi, Apple Inc., IEEE, Hertz Foundation, Car, ADI, Nasdaq, Gravity Gradient Technology Satellite, National Academy of Engineering, Research, Corporation, CEO, Carnegie Mellon University, Analog Devices, Software, Semiconductor, Stanford University, National academy, Doctor of Philosophy, National Association, Silicon, Leadership, Management, Broadcom Inc.

IRVINE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Syntiant Corp., a provider of deep learning solutions for always-on edge AI applications, today announced the addition of Edward Frank, Ph.D., to its board of directors.

Key Points: 
  • IRVINE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Syntiant Corp., a provider of deep learning solutions for always-on edge AI applications, today announced the addition of Edward Frank, Ph.D., to its board of directors.
  • Dr. Frank also served as corporate vice president, research and development, of Broadcom, a leading developer of integrated circuits for broadband communication.
  • Were thrilled to add him to our impressive roster of board directors as we enter the next chapter for Syntiant.
  • He is a Fellow of the IEEE and a National Association of Corporation Directors Board Leadership Fellow.

InteliChart Expands Leadership Team with New Chief Operating Officer

Retrieved on: 
Tuesday, October 25, 2022
Michigan State University, Growth, Machine learning, Patient portal, Software as a service, Patient, Hospital, MBA, University, EHealth, MSEE, Industry, CEO, University of Chicago Booth School of Business, Georgia Institute of Technology School of Computational Science & Engineering, EHR, Solution, BSEE, Leadership, Management, Medicine

CHARLOTTE, N.C., Oct. 25, 2022 /PRNewswire/ -- InteliChart, a leader in patient engagement solutions for health care providers of all sizes, announces the appointment of Anthony L. Carter as its new chief operating officer. Carter brings over 20 years of experience in overhauling products and services to InteliChart, identifying opportunities to grow top-line revenues, driving product development, and guiding leadership teams to success.  

Key Points: 
  • CHARLOTTE, N.C., Oct. 25, 2022 /PRNewswire/ -- InteliChart , a leader in patient engagement solutions for health care providers of all sizes, announces the appointment of Anthony L. Carter as its new chief operating officer.
  • Carter brings over 20 years of experience in overhauling products and services to InteliChart, identifying opportunities to grow top-line revenues, driving product development, and guiding leadership teams to success.
  • "InteliChart is excited to be gaining yet another industry veteran talent with the addition of Anthony," said Gary Hamilton, CEO of InteliChart.
  • For more than a decade, InteliChart has successfully partnered with healthcare organizations across the country to streamline workflows and deliver healthier outcomes.

Rocket Lab Welcomes Dr. Edward Frank to Board of Directors

Retrieved on: 
Tuesday, September 6, 2022
Technology, Aerospace, Manufacturing, Satellite, Neutron, National Association, Software, Research, Analog Devices, Corporation, CEO, Moon, SITM, Computer science, Development, Carnegie Mellon University, BSEE, Trustee, NASA, Board, Hertz Foundation, Broadcom Inc., Apple, Board of directors, Apple Inc., Gravity Gradient Technology Satellite, Qualcomm Inc. v. Broadcom Corp., National academy, Leadership, Nasdaq, MSEE, National Academy of Engineering, Rocket Lab, Stanford University, Company, Communication, Electron, IEEE, Wi-Fi, Lab, Growth, Research and development, Management, Communications satellite, Mars, Photon

Rocket Lab USA, Inc (Nasdaq: RKLB ) (Rocket Lab or the Company) a leading launch and space systems company, today announced that Dr. Edward Frank has been elected to the Companys Board of Directors.

Key Points: 
  • Rocket Lab USA, Inc (Nasdaq: RKLB ) (Rocket Lab or the Company) a leading launch and space systems company, today announced that Dr. Edward Frank has been elected to the Companys Board of Directors.
  • Dr. Frank joins Rocket Labs board following more than 35 years of leadership in innovative technology companies, including serving at Apple, Inc. from 2009 until 2013 as Vice President, Macintosh Hardware Systems Engineering.
  • Ed is a fantastic addition to the Rocket Lab Board, bringing decades of deep tech experience to our team.
  • Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success.